Drug reference
Menopausal symptoms (in women with at least 12 months since last menses for whom treatment with progestogen- containing therapy is not appropriate) ▶BY MOUTH ▶Adult: 0.45/20 mg daily continuously DOSE EQUIVALENCE AND CONVERSION ▶Dose expressed as x/y mg conjugated oestrogens/bazedoxifene.
PDF page 820
→Appendix 1: hormone replacement therapy
PDF page 820
▶Common or very common Abdominal pain. constipation. diarrhoea. drowsiness. dry mouth. hot flush. muscle complaints. nausea. peripheral oedema. skin reactions. vulvovaginal candidiasis ▶Uncommon Cholecystitis ▶Rare or very rare Embolism and thrombosis ▶Frequency not known Dry eye. eye disorders. eye inflammation. eye pain. palpitations. vision disorders
PDF page 820
There can be variation in the licensing of different medicines containing the same drug. Modified-release tablet CAUTIONARY AND ADVISORY LABELS 3, 25 ▶Duavive (Pfizer Ltd) Conjugated oestrogens 450 microgram, Bazedoxifene (as Bazedoxifene acetate) 20 mg Duavive 0.45mg/20mg modified- release tablets | 28 tablet P £15.00 DT = £15.00
PDF page 821
0.45/20 mg daily continuously
First-line fragment. Read the complete Indications and Dose section above.
PDF page 820
